Category: Hematology / Myelodysplastic Syndrome
Myelodysplastic Syndromes (MDS) are a group of heterogeneous clonal hematopoietic stem cell disorders characterized by ineffective hematopoiesis, peripheral cytopenias, and a high risk of progression to acute myeloid leukemia.
Approximately 3-5 cases per 100,000 population per year, increasing with age, according to the MDS Foundation.
Discover the latest clinical trials and treatments for Myelodysplastic Syndromes on JourneyForHealth.
View Full Analysis